PMID: 3759530Oct 1, 1986Paper

Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostate

International Journal of Radiation Oncology, Biology, Physics
T F DeLaneyG R Prout

Abstract

Fifty-four patients with clinically and surgically localized prostatic carcinoma were treated with low-dose preoperative irradiation (1,050 cGy), pelvic lymphadenectomy, and interstitial 125Iodine implantation. The follow-up range is 2 to 9 years with a median follow-up of 5 years. Overall local tumor control is 92%. Actuarial 5-year survival is 86% and the actuarial disease-free survival at 5 years is 73%. Patients with poorly differentiated tumors have a significantly worse actuarial survival (62%) at 5 years than patients with well (95%) or moderately well differentiated tumors (93%), p = 0.04. Disease-free survival at 5 years was influenced by grade: well (100%), moderate (60%), and poor (48%), p = 0.03. Multivariate regression analysis indicates that only the degree of differentiation (p = 0.05) significantly impacts on survival. Both degree of differentiation (p = 0.04) and nodal status (p = 0.03) significantly influence disease-free survival. Potency has been maintained in 71% of patients potent at the time of implantation. Late reactions have been acceptable to date: bladder outlet obstruction (13%), mild proctitis (13%), cystourethritis (6%), incontinence (2%), and prostatic calculi (2%).

References

Sep 1, 1977·International Journal of Radiation Oncology, Biology, Physics·W J NegliaD E Johnson
Mar 1, 1979·International Journal of Radiation Oncology, Biology, Physics·C C LingW U Shipley
May 1, 1978·International Journal of Radiation Oncology, Biology, Physics·B H van der Werf-Messing
Jul 1, 1977·International Journal of Radiation Oncology, Biology, Physics·B S HilarisW Barzell
Oct 1, 1985·International Journal of Radiation Oncology, Biology, Physics·R E PeschelT P Mate
Mar 1, 1983·International Journal of Radiation Oncology, Biology, Physics·J D Cox, R W Kline
Mar 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S A LeibelS Kramer

❮ Previous
Next ❯

Citations

Nov 14, 1997·Seminars in Surgical Oncology·H H Holm
Nov 14, 1997·Seminars in Surgical Oncology·H RagdeK Landin
May 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G ArcangeliC N Sternberg
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·R G StockJ K DeWyngaert
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R G StockC Iannuzzi
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Luca IncrocciPeter C Levendag
Apr 8, 1998·International Journal of Radiation Oncology, Biology, Physics·K Hu, K Wallner
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J D Morton, R E Peschel
Nov 1, 1996·The Urologic Clinics of North America·J C BlaskoP D Grimm
Jul 1, 1991·International Journal of Radiation Oncology, Biology, Physics·J N RoyC C Ling
Feb 1, 1993·Cancer·A T Porter, J D Forman
Jun 26, 1999·The British Journal of Surgery·T Lehnert
Jan 12, 2005·Cancer Investigation·Ulrike Boehmer, Richard K Babayan
Sep 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C A PerezM A Lockett
Jun 1, 1996·Hematology/oncology Clinics of North America·P D GrimmD Clarke
Mar 15, 1993·International Journal of Radiation Oncology, Biology, Physics·V E ArterberyZ Fuks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
G M Giles, L W Brady
International Journal of Radiation Oncology, Biology, Physics
J D Morton, R E Peschel
International Journal of Radiation Oncology, Biology, Physics
R E PeschelT P Mate
International Journal of Radiation Oncology, Biology, Physics
E W KwongH S Smith
International Journal of Radiation Oncology, Biology, Physics
C D KoprowskiL W Brady
© 2021 Meta ULC. All rights reserved